Koiti Inokuchi

3.9k total citations
145 papers, 2.2k citations indexed

About

Koiti Inokuchi is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Koiti Inokuchi has authored 145 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Hematology, 53 papers in Genetics and 41 papers in Molecular Biology. Recurrent topics in Koiti Inokuchi's work include Chronic Myeloid Leukemia Treatments (57 papers), Chronic Lymphocytic Leukemia Research (41 papers) and Acute Myeloid Leukemia Research (40 papers). Koiti Inokuchi is often cited by papers focused on Chronic Myeloid Leukemia Treatments (57 papers), Chronic Lymphocytic Leukemia Research (41 papers) and Acute Myeloid Leukemia Research (40 papers). Koiti Inokuchi collaborates with scholars based in Japan, United States and Australia. Koiti Inokuchi's co-authors include Hiroki Yamaguchi, Kazuo Dan, Takeo Nomura, K Dan, Takashi Shimada, Hayato Tamai, Hideto Tamura, Mariko Ishibashi, Tsuneaki Hirakawa and Makoto Futaki and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Blood.

In The Last Decade

Koiti Inokuchi

142 papers receiving 2.1k citations

Peers

Countries citing papers authored by Koiti Inokuchi

Since Specialization

Citations

This map shows the geographic impact of Koiti Inokuchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koiti Inokuchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koiti Inokuchi more than expected).

Fields of papers citing papers by Koiti Inokuchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koiti Inokuchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koiti Inokuchi. The network helps show where Koiti Inokuchi may publish in the future.

Co-authorship network of co-authors of Koiti Inokuchi

This figure shows the co-authorship network connecting the top 25 collaborators of Koiti Inokuchi. A scholar is included among the top collaborators of Koiti Inokuchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koiti Inokuchi. Koiti Inokuchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The levels of serum soluble CD86 are correlated with the expression of CD86 variant 3 gene and are prognostic indicators in patients with myeloma 2023 ·Experimental Hematology ·(unknown), Mariko Ishibashi, Hiroshi Handa, Makoto Sasaki, Yoichi Imai, (unknown), Shigeki Ito, (unknown), (unknown), (unknown), Norio Komatsu, Junji Tanaka, Takeshi Odajima, Hiroki Sugimori, Hiroki Yamaguchi, Koiti Inokuchi, Hideto Tamura	2
2	Durvalumab Combined with Immunomodulatory Drugs (IMiD) Overcomes Suppression of Antitumor Responses due to IMiD-induced PD-L1 Upregulation on Myeloma Cells 2021 ·Molecular Cancer Therapeutics ·Mariko Ishibashi, Junichi Yamamoto, Takumi Ito, Hiroshi Handa, (unknown), Koiti Inokuchi, Rimpei Morita, Hideto Tamura	1
3	The SLAMF3 rs509749 polymorphism correlates with malignant potential in multiple myeloma 2020 ·Experimental Hematology ·Mariko Ishibashi, (unknown), (unknown), (unknown), (unknown), (unknown), Koiti Inokuchi, Rimpei Morita, Hideto Tamura	3
4	The sensitivity of the FLT3-ITD detection method is an important consideration when diagnosing acute myeloid leukemia 2020 ·Leukemia Research Reports ·Masahiro Sakaguchi, (unknown), Hiroki Yamaguchi, Yuho Najima, Katsuhiro Shono, Atsushi Marumo, Ikuko Omori, Yusuke Fujiwara, Kazuki Terada, Shunsuke Yui, Satoshi Wakita, (unknown), Kunihito Arai, Tomoaki Kitano, Noriko Doki, Kazuteru Ohashi, Koiti Inokuchi	10
5	Efficacy and safety of tyrosine kinase inhibitors for newly diagnosed chronic-phase chronic myeloid leukemia over a 5-year period: results from the Japanese registry obtained by the New TARGET system 2019 ·International Journal of Hematology ·(unknown), Masahiro Kizaki, Naoto Takahashi, Noriyoshi Iriyama, Shinichiro Okamoto, Takaaki Ono, Noriko Usui, Koiti Inokuchi, Chiaki Nakaseko, Mineo Kurokawa, Masahiko Sumi, Fumihiko Nakamura, Tatsuya Kawaguchi, Ritsuro Suzuki, Kazuhito Yamamoto, Kazunori Ohnishi, Itaru Matsumura, Tomoki Naoe	25
6	Regulatory T cell inhibition by dasatinib is associated with natural killer cell differentiation and a favorable molecular response—The final results of the D-first study 2018 ·Leukemia Research ·Yuho Najima, Chikashi Yoshida, Noriyoshi Iriyama, Shin Fujisawa, Hisashi Wakita, Shigeru Chiba, Shinichiro Okamoto, (unknown), Naoki Takezako, Takashi Kumagai, Kazuma Ohyashiki, Jun Taguchi, Shingo Yano, Tadahiko Igarashi, Yasuji Kouzai, Satoshi Morita, Junichi Sakamoto, Hisashi Sakamaki, Koiti Inokuchi	29
7	Myeloma Drug Resistance Induced by Binding of Myeloma B7-H1 (PD-L1) to PD-1 2016 ·Cancer Immunology Research ·Mariko Ishibashi, Hideto Tamura, (unknown), (unknown), Namiko Okuyama, (unknown), (unknown), Inhak Choi, Koji Tamada, Koiti Inokuchi	78
8	JAK2 mutation and acute coronary syndrome complicated with stent thrombosis 2016 ·Heart and Vessels ·Toru Inami, Masahiro Okabe, M. Matsushita, Nobuaki Kobayashi, Koiti Inokuchi, Noritake Hata, Yoshihiko Seino, Wataru Shimizu	8
9	Clinical features of Japanese polycythemia vera and essential thrombocythemia patients harboring CALR, JAK2V617F, JAK2Ex12del, and MPLW515L/K mutations 2015 ·Leukemia Research ·Masahiro Okabe, Hiroki Yamaguchi, Kensuke Usuki, Yutaka Kobayashi, Eri Kawata, Junya Kuroda, Shinya Kimura, Kenji Tajika, Seiji Gomi, Nobuyoshi Arima, (unknown), Shigeki Ito, Masayuki Koizumi, Yoshikazu Ito, Satoshi Wakita, Kunihito Arai, Tomoaki Kitano, (unknown), Kazuo Dan, Koiti Inokuchi	11
10	Inhibition of S100A6 induces GVL effects in MLL/AF4-positive ALL in human PBMC-SCID mice 2014 ·Bone Marrow Transplantation ·Hayato Tamai, Keisuke Miyake, Hiroki Yamaguchi, Takashi Shimada, K Dan, Koiti Inokuchi	9
11	Sustained upregulation of effector natural killer cells in chronic myeloid leukemia after discontinuation of imatinib 2013 ·Cancer Science ·Izuru Mizoguchi, Takayuki Yoshimoto, Seiichiro Katagiri, Junichiro Mizuguchi, Tetsuzo Tauchi, Yukihiko Kimura, Koiti Inokuchi, Junko H. Ohyashiki, Kazuma Ohyashiki	29
12	Importance of Relative Dose Intensity in Chemotherapy for Diffuse Large B-Cell Lymphoma 2011 ·Journal of Clinical and Experimental Hematopathology ·Hiroki Yamaguchi, Tsuneaki Hirakawa, Koiti Inokuchi	41
13	Current and future perspectives on the TARGET system: the registration system for Glivec® established by the JSH 2008 ·International Journal of Hematology ·(unknown), Masahiro Kizaki, Shinichiro Okamoto, Tetsuzo Tauchi, Hideo Tanaka, Mitsune Tanimoto, Koiti Inokuchi, Tohru Murayama, Yoshio Saburi, Masayuki Hino, Mitsuru Tsudo, Taizo Shimomura, Yasushi Isobe	10
14	The study for loss of bcl-xs expression as a prognostic factor in acute myeloid leukemia 2002 ·Leukemia Research ·Hiroki Yamaguchi, Koiti Inokuchi, Kazuo Dan	16
15	Establishment of a cell line with AML1‐MTG8, TP53, and TP73 abnormalities from acute myelogenous leukemia 2001 ·Genes Chromosomes and Cancer ·Koiti Inokuchi, Hiroyuki Hamaguchi, Masafumi Taniwaki, Hiroki Yamaguchi, Sakae Tanosaki, Kazuo Dan	7
16	Importance of a Cleaning in Upper Airways by Using Povidone Iodine for the Prevention of Nosocomial Pneumonia 2001 ·Kansenshogaku zasshi ·Hiroaki Masaki, Hiroyuki Yoshimine, (unknown), Norichika Asoh, (unknown), (unknown), Koiti Inokuchi, Hiroshi Watanabe, Kentaro Watanabe, (unknown), (unknown)	5
17	Heterogenous expression of bcr‐abl fusion mRNA in a patient with Philadelphia‐chromosome‐positive acute lymphoblastic leukaemia 1997 ·British Journal of Haematology ·Koiti Inokuchi, Makoto Futaki, Hideki Hanawa, Sakae Tanosaki, Hiroki Yamaguchi, (unknown), Takeo Nomura, Kazuo Dan	12
18	Marked basophilia in acute promyelocytic leukaemia treated with all‐trans retinoic acid: molecular analysis of the cell origin of the basophils 1994 ·British Journal of Haematology ·(unknown), Koiti Inokuchi, Kazuo Dan, Takeo Nomura	11
19	The Relationship Between the Type of bcr-abl Hybrid Messenger RNA and Thrombopoiesis in Philadelphia-Positive Chronic Myelogenous Leukemia 1993 ·Leukemia & lymphoma ·Koiti Inokuchi, Takeo Nomura	14
20	Site-Specific Demethylation and Normal Chromatin Structure of the Human Dihydrofolate Reductase Gene Promoter after Transfection into CHO Cells 1987 ·Molecular and Cellular Biology ·Takashi Shimada, Koiti Inokuchi, Arthur W. Nienhuis	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact